Hospital Hours: Monday-Friday: 8am-6pm | Saturday: 8am-4pm
(519) 896-0532
IMHA, or Immune-Mediated Hemolytic Anemia, is a serious and life-threatening condition that affects dogs. It is a condition in which the body's immune system attacks and destroys its own red blood cells, leading to anemia and potentially, organ failure due to thromboembolic disease. Understanding IMHA in dogs is important for owners, as early detection and prompt treatment can greatly improve the chances of recovery.
Immune-mediated hemolytic anemia in dogs is an autoimmune disorder resulting in the malfunction of the immune system and subsequent destruction of red blood cells and anemia. IMHA is one of the most common types of hemolytic anemia that can be found in dogs. Additionally, IMHA can either be a primary condition or be secondary to another underlying health problem.
The exact cause of IMHA in dogs is still unknown, however, it is believed that it is an autoimmune disorder. Secondary causes of IMHA in dogs may be triggered by underlying diseases or conditions such as infections (viral or bacterial), certain cancers, drug reactions, vaccinations, and other immune-mediated disorders. In most cases, however, the cause of IMHA in dogs is idiopathic, meaning unknown, which is the primary form of IMHA.
The development of IMHA in dogs is complex and includes the immune system’s production of antibodies that attach to red blood cells, causing them to rupture or be removed from circulation by the spleen in a process called hemolysis.
As a result, anemia occurs as fewer red blood cells are available for oxygen transport throughout the body. IMHA can also lead to thromboembolic disease, which is the formation of an abnormal blood clot in small vessels that can cause organ damage or failure.
IMHA in dogs can cause a range of symptoms, including:
IMHA in dogs is diagnosed through a combination of physical examination, blood tests, and other diagnostic tests as needed. The following steps are typically involved in the diagnosis of IMHA in dogs:
It is important to note that a definitive diagnosis of IMHA in dogs may require multiple tests and can take some time to confirm. However, prompt diagnosis and treatment are crucial in improving the chances of recovery for dogs with IMHA.
The goal of IMHA treatment for dogs is to control the immune system and stop the destruction of red blood cells. To achieve this, a combination of medications and supportive care is typically used.
Medications used to treat IMHA in dogs include corticosteroids (such as prednisone or dexamethasone), immunosuppressants (such as cyclosporine and azathioprine), and other supportive medications. Generally, corticosteroids are prescribed for dogs for a period of 3-6 months, while immunosuppressant drugs may be necessary anywhere from 4 to 8 months.
As thromboembolism (e.g. pulmonary thromboembolism) is a frequent complication of IMHA, it is critical to incorporate antithrombotic therapy into the treatment of IMHA in dogs. Common antithrombotic medications include aspirin, heparin, and clopidogrel.
Interestingly, splenectomy is sometimes used as a supplemental treatment for dogs with IMHA and those who have continuous relapses or require chronic immunosuppressive therapy. A retrospective analysis of 10 dogs diagnosed with IMHA that were treated with splenectomy in conjunction with medical therapy revealed a notable improvement in outcome. More studies are required however for us to definitively recommend this treatment option.
Some dogs suffering from IMHA undergo a dangerous anemia that necessitates a blood transfusion in order to stabilize their condition. Additionally, many veterinarians will also recommend stomach protectants such as omeprazole and sucralfate to reduce the potential for gastrointestinal ulceration.
The outcome of treatment for IMHA in dogs can vary greatly, with some cases having a guarded prognosis. Research has demonstrated that the survival rate of hospital discharge ranges from 50-90%. The mortality rate is highest in the initial two weeks following the initiation of medical management and future relapses may occur.
To avoid future occurrences of IMHA, it is important to eliminate any drugs or vaccines that may have triggered the disorder. Many veterinarians choose to minimize or even abstain from administering vaccinations in order to prevent further stimulation of an already compromised immune system.
Evan's syndrome is a form of IMHA in dogs where the red blood cells and platelets are destroyed by the immune system. The signs and symptoms of IMHA will be present as well as signs of a clotting disorder such as bleeding from the nose and bruising.
Primary IMHA is most commonly seen in younger to middle-aged dogs, and females are especially at risk. Cocker spaniels are the most at risk followed by schnauzer, collie, doberman pinscher, springer spaniel and poodle.
Certain infections, such as those caused by tick-borne diseases such as Ehrlichiosis and Anaplasmosis, bacterial infections such as mycoplasma, and parasitic causes such as whipworm, can trigger IMHA in dogs. Additionally, it has been documented that leptospirosis can trigger IMHA in dogs.
In conclusion, IMHA can be a serious and potentially life-threatening disease in dogs. Common symptoms of IMHA include lethargy, pale gums, difficulty breathing, and increased heart rate. Diagnosis of IMHA in dogs is based on a combination of clinical signs, laboratory tests, and imaging studies. The goal of IMHA treatment for dogs is to control the immune system and stop the destruction of red blood cells with a combination of medications and supportive care. While the prognosis for IMHA in dogs may be guarded, early diagnosis and prompt treatment can improve the chances of recovery. To help prevent IMHA in dogs, it is important to eliminate any drugs or vaccines that may have triggered the disorder and minimize vaccinations when necessary.
It is important for pet owners to speak with their veterinarian if they suspect their dog may be suffering from the disorder. We hope this information was helpful and please contact your veterinarian if you have any questions.
